<i>In vitro</i>and<i>in vivo</i>characterization of the bifunctional μ and δ opioid receptor ligand UFP‐505
Nikolas Dietis(University of Leicester), David G. Lambert(Griffith University), Girolamo Calò(University of Padua), Hitomi Niwa(University of Leicester), Valentina Ruggieri(University of Modena and Reggio Emilia), J. McDonald, Monica Filaferro(University of Modena and Reggio Emilia), Laura Micheli(University of Florence), G. Vitale(Roche (Switzerland)), Ryuji Tose(University of Leicester), Severo Salvadori(University of Ferrara), Renzo Guerrini(Meyer Children's Hospital), David J. Rowbotham(Leicester Royal Infirmary), Carla Ghelardini(Creative Commons)
Cited by 18
Related Papers
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
Somatic Mutations in Cerebral Cortical Malformations
|New England Journal of Medicine|2014|394